Drug Discovery, Antibodies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
68
NCT04788459
Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 25, 2021
Completion: Dec 7, 2021
Loading map...